Co-Authors
This is a "connection" page, showing publications co-authored by Mario Venditti and Marco Falcone.
Connection Strength
1.155
-
Corrigendum: Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency. Sci Rep. 2018 Aug 09; 8:47005.
Score: 0.195
-
Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort. Antimicrob Agents Chemother. 2018 04; 62(4).
Score: 0.190
-
Follow-up Blood Cultures: A 2.0 Diagnostic Tool in Patients With Gram-Negative Bacteremia and Septic Thrombophlebitis. Clin Infect Dis. 2018 03 19; 66(7):1154-1155.
Score: 0.190
-
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis. Expert Rev Anti Infect Ther. 2017 09; 15(9):807-818.
Score: 0.183
-
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia. New Microbiol. 2017 Jul; 40(3):205-207.
Score: 0.181
-
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis. J Antimicrob Chemother. 2010 Oct; 65(10):2266-7.
Score: 0.112
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.058
-
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia. Clin Infect Dis. 2017 Jun 01; 64(11):1486-1493.
Score: 0.045